Coto de Caza, CA, United States of America

John W Goodin

This inventor holds 55 USPTO granted patents, primarily in Fluid Testing Systems (CPC class B01L). Top assignees: Escreen, Inc., Cambro Manufacturing Company, Black Decker Inc.. Active years: 1976-2015.


% Patents Active = 85.5

Average Co-Inventor Count = 2.3

ph-index = 21

Forward Citations = 1,264(Granted Patents)

Forward Citations (Not Self Cited) = 1,220(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Long Beach, CA (US) (1976 - 1986)
  • Coto de Caza, CA (US) (1992 - 2015)

Company Filing History:

goldMedal10 out of 15 
 
Escreen, Inc.
 patents
silverMedal8 out of 212 
 
Cambro Manufacturing Company
 patents
bronzeMedal7 out of 5,073 
 
Black Decker Inc.
 patents
4. 6 out of 116 
 
L.r. Nelson Corporation
 patents
5. 3 out of 5 
 
J & M Coffee Container Company, Inc.
 patents
6. 2 out of 43 
 
Hornady Manufacturing Company
 patents
7. 2 out of 22 
 
North States Industries, Inc.
 patents
8. 2 out of 107 
 
Roger Cleveland Golf Company, Inc.
 patents
9. 2 out of 11 
 
Woodward Laboratories, Inc.
 patents
10. 1 out of 9 
 
Admotion Corporation
 patents
11. 1 out of 49 
 
Baxter Laboratories, Inc.
 patents
12. 1 out of 591 
 
Emhart Inc.
 patents
13. 1 out of 4 
 
Epicenter, Incorporated
 patents
14. 1 out of 1 
 
Master Product Manufacturing Company Inc.
 patent
15. 1 out of 3 
 
Nelson; L. R.
 patents
16. 1 out of 1 
 
Screen, Inc.
 patent
17. 1 out of 2 
 
The French Co.
 patents
18. 5 out of 834,350 
Other
 patents

Years Active: 1976-2015

Loading Chart...
Areas of Expertise:
Fluid Specimen
Testing System
Beverage Container
Sample Collection
Fluid Dispenser
Storage Device
Security Gate
Dish Rack
Reloader
Portable Sink
Hose Nozzle
Vacuum Cleaner
55 patents (USPTO):Explore Patents

Title: Innovations by John W. Goodin: A Pioneer in Specimen Testing

Introduction

John W. Goodin, based in Coto de Caza, California, is a prolific inventor known for his contributions to fluid specimen testing technology. With an impressive portfolio of 55 patents, Goodin has focused his efforts on developing innovative methods and systems that enhance the accuracy and security of specimen handling and testing.

Latest Patents

Among his latest innovations, Goodin has developed a "Method of Securing a Chain of Custody of a Specimen of a Donor." This method effectively prevents tampering or accidental mismanagement of specimens by implementing a tamper-evident seal. This seal is designed to indicate if an assaying device has been compromised, featuring a label with a machine-readable indicia area.

Additionally, he created a "System for Automatically Testing a Fluid Specimen," which indicates the presence of specified chemical components in a specimen. This advanced system utilizes an assaying device with a collection cup and a cap that carries a test strip. It includes an integrated aliquot delivery mechanism, which automatically wets the test strip with an aliquot from the fluid specimen. The system operates alongside an electronic reader device designed to actuate the delivery mechanism and analyze the test strip's reaction.

Career Highlights

Throughout his career, Goodin has worked with notable companies such as Escreen, Inc. and Cambro Manufacturing Company. His expertise in specimen analysis and testing has positioned him as a valuable contributor to the fields of healthcare and laboratory technology.

Collaborations

Goodin has collaborated with several professionals in the industry, including colleagues like Murray Lappe and Keith Patten. Their collective efforts have further advanced the innovation of specimen testing, driving developments that improve safety and reliability in the field.

Conclusion

John W. Goodin's patents exemplify his commitment to innovation in specimen testing and handling. As he continues to refine his techniques and methodologies, Goodin stands out as a key figure in the advancement of technologies that ensure the integrity of fluid specimens, ultimately contributing to improved healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…